SEARCH · Search PubMed
Results for “Insurance Selection Bias”
Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
International forum on ulcerative colitis. Risk selection aspects of ulcerative colitis.
Explore the source record for details and available documents.
Medicaid: new generation of managed care improves access, delivery.
Explore the source record for details and available documents.
Examining life's (genomic) code means reexamining society's long-held codes.
Explore the source record for details and available documents.
Applying theological developments to bioethical issues such as genetic screening.
Catholic movements within the centre of Roman Catholic doctrine recently have discussed Trinitarian theology as applied to sciences, arts, economics, health and other social areas. We explore the possibilities Trinitarian theology offers to bioethical debate, concentrating particularly on genetic screening and testing. It is important therefore to analyse the philosophical implications of this approach onto the bioethical world, where much disagreement occurs on fundamental issues. It is Catholic basic teaching to recognize and see God's hand in plurality, not merely as a cliche and then doing what we feel is right, but to recognize how to live in a pluralistic world. We recognize, in agreement with these theologians, that in order for a Trinitarian mode of understanding to be used by those doing bioethical debate, there is a need to depart from fundamentalism.
Ethical considerations in managed care: a commentary.
Explore the source record for details and available documents.
Victims of genetic discrimination speak up.
Explore the source record for details and available documents.
Genetic screening and insurance: too valuable an underwriting tool to be banned from the system.
Explore the source record for details and available documents.
Testing the limits of care. Concern about 'genetic discrimination' from employers and insurers trying to keep costs down casts a pall on genetic testing.
The specter of "genetic discrimination" casts a long shadow over the breakthroughs and the promise of advances in genetic testing. Nearly 70% of respondents in a recent survey said they are concerned about who would have access to genetic data. But scientists say the tests can offer real benefits. Paul Femhoff, left, says a child identified with fragile X syndrome, for example, could benefit from early treatment.
The elderly and the discriminatory use of genetic information.
Explore the source record for details and available documents.
Consumer-directed plans.
Explore the source record for details and available documents.
North Carolina high-risk insurance pools.
Imagine this: You are a 58-year-old man. You have worked all your life, paid taxes, and helped support your family. Two years ago you had a mild heart attack. Your wife has diabetes and high blood pressure. Luckily, you had health insurance through your job that helped you pay for the hospitalization, doctor's visits, and necessary medications for you and your wife. With a new diet, exercise, and the medications, you both are doing well managing your health problems. A little over a year ago, you lost your insurance when your company downsized. You found another job, but your current employer doesn't offer insurance. Your wife also works, but she works for a small employer that does not offer coverage. So, you pay approximately dollar 600/month for continuation coverage (COBRA) for your wife and yourself through your former employer. Last month, you found out your COBRA coverage is about to end. You want to continue to buy insurance coverage, but you were told that purchasing a comprehensive policy with a dollar 1,000 deductible (70% coinsurance) that covers your needed medications would cost more than dollar 4,000/month for your wife and yourself.
Health savings accounts: should you consider these plans for your own staff?
Two of the latest buzzwords to take center stage in healthcare are health savings accounts (HSAs) and consumer-driven healthcare, but who knows what they mean? This article defines these two concepts and relates how they will work together to save money for consumers and drive down the cost of healthcare. Should physicians be concerned about the impact these initiatives will have on their practices? Physicians should always be concerned about what is going in the marketplace and do everything they can to prepare for the way new plans will affect patient behavior. As an employer, HSAs are worth considering for coverage for your practice staff Employers of all sizes are looking into ways these plans will save money yet provide the adequate coverage that employees hold dear. This article considers the characteristics of HSAs and explores the administrative and operational challenges HSAs will present.
An exploration of the legal and socio-ethical implications of predictive genetic testing of children.
This article explores the current position in relation to predictive genetic testing of children, highlighting some of the legal and socio-ethical issues and complexities that such testing presents. It evaluates the existing regulatory framework for predictive genetic testing of children in Australia, including the possible role of the Family Court in protecting children from inappropriate testing, and suggests that introducing a more interventionist approach would create its own difficulties. The article also considers a particular issue arising in the context of predictive genetic testing of children which the ALRC/AHEC inquiry canvassed concerning disclosure obligations to insurers. The article argues that creating an exception to established principles of disclosure would mitigate the impact of predictive genetic testing of children and would be consistent with international instruments which seek to protect against unfair genetic discrimination.
Controversial move. Leavitt seeks to tie genetic info to e-health records.
Explore the source record for details and available documents.
Genetic testing and discrimination: how private is your information?
Explore the source record for details and available documents.
A simultaneous equations model of employer strategies for controlling health benefit costs.
We estimated a simultaneous equations model of employer health insurance cost control strategies and their effectiveness in reducing health plan premiums. We hypothesized that as premiums increase, employers will shop more actively for health plans, place incentives on providers to control medical care costs, increase employee cost sharing for medical care, and be more likely to offer an HMO. In turn, we expected each of these strategies, except offering an HMO, to reduce average health plan premiums. The model was estimated with 1985 data from a sample of 922 Minnesota employers. We found that high premiums are related to three of the proposed cost control strategies. Employers with higher premiums shop more, are more likely to seek provider incentives, and offer an HMO. However, these employers appear to have lower employee cost sharing. Employers with higher employee cost sharing and those that offer an HMO had lower health plan premiums.